Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res June 15 2013 19 (12) 3109-3109;

CCR Translations

  • CCR Translations
    Stearoyl Co-A Desaturase 1 as a ccRCC Therapeutic Target: Death by Stress
    Janet Y. Leung and William Y. Kim
    Clin Cancer Res June 15 2013 19 (12) 3111-3113; DOI:10.1158/1078-0432.CCR-13-0800

Molecular Pathways

  • Molecular Pathways
    Molecular Pathways: Extracting Medical Knowledge from High-Throughput Genomic Data
    Theodore C. Goldstein, Evan O. Paull, Matthew J. Ellis and Joshua M. Stuart
    Clin Cancer Res June 15 2013 19 (12) 3114-3120; DOI:10.1158/1078-0432.CCR-12-2093

Human Cancer Biology

  • Human Cancer Biology
    microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics
    Alba Navarro, Guillem Clot, Miriam Prieto, Cristina Royo, Maria Carmela Vegliante, Virginia Amador, Elena Hartmann, Itziar Salaverria, Sílvia Beà, Jose Ignacio Martín-Subero, Andreas Rosenwald, German Ott, Adrian Wiestner, Wyndham H. Wilson, Elías Campo and Luis Hernández
    Clin Cancer Res June 15 2013 19 (12) 3121-3129; DOI:10.1158/1078-0432.CCR-12-3077

  • Human Cancer Biology
    Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia
    Marta Lionetti, Pellegrino Musto, Maria Teresa Di Martino, Sonia Fabris, Luca Agnelli, Katia Todoerti, Giacomo Tuana, Laura Mosca, Maria E. Gallo Cantafio, Vitina Grieco, Gabriella Bianchino, Fiorella D'Auria, Teodora Statuto, Carmela Mazzoccoli, Luciana De Luca, Maria Teresa Petrucci, Massimo Offidani, Francesco Di Raimondo, Antonietta Falcone, Tommaso Caravita, Paola Omede', Fortunato Morabito, Pierfrancesco Tassone, Mario Boccadoro, Antonio Palumbo and Antonino Neri
    Clin Cancer Res June 15 2013 19 (12) 3130-3142; DOI:10.1158/1078-0432.CCR-12-2043

  • Human Cancer Biology
    Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
    Klaus G. Griewank, Henrike Westekemper, Rajmohan Murali, Monika Mach, Bastian Schilling, Thomas Wiesner, Tobias Schimming, Elisabeth Livingstone, Antje Sucker, Florian Grabellus, Claudia Metz, Daniela Süsskind, Uwe Hillen, Michael R. Speicher, Scott E. Woodman, Klaus-Peter Steuhl and Dirk Schadendorf
    Clin Cancer Res June 15 2013 19 (12) 3143-3152; DOI:10.1158/1078-0432.CCR-13-0163

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
    Michael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L. Kosasih, Daniel Sommermeyer, Michael C. Jensen, Christoph Rader and Stanley R. Riddell
    Clin Cancer Res June 15 2013 19 (12) 3153-3164; DOI:10.1158/1078-0432.CCR-13-0330

  • Cancer Therapy: Preclinical
    Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
    Orin Bloch, Courtney A. Crane, Rajwant Kaur, Michael Safaee, Martin J. Rutkowski and Andrew T. Parsa
    Clin Cancer Res June 15 2013 19 (12) 3165-3175; DOI:10.1158/1078-0432.CCR-12-3314

  • Cancer Therapy: Preclinical
    IL-17–Mediated M1/M2 Macrophage Alteration Contributes to Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaws
    Qunzhou Zhang, Ikiru Atsuta, Shiyu Liu, Chider Chen, Shihong Shi, Songtao Shi and Anh D. Le
    Clin Cancer Res June 15 2013 19 (12) 3176-3188; DOI:10.1158/1078-0432.CCR-13-0042

  • Cancer Therapy: Preclinical | Free Article
    ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
    Laura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, Jason M. Beckta, Nicholas C.K. Valerie, Mary Tokarz, Bret R. Adams, Alison F. Wagner, Ashraf Khalil, Donna Gilfor, Sarah E. Golding, Sumitra Deb, David G. Temesi, Alan Lau, Mark J. O'Connor, Kevin S. Choe, Luis F. Parada, Sang Kyun Lim, Nitai D. Mukhopadhyay and Kristoffer Valerie
    Clin Cancer Res June 15 2013 19 (12) 3189-3200; DOI:10.1158/1078-0432.CCR-12-3408

  • Cancer Therapy: Preclinical
    Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines
    Jana Jeschke, Heather M. O'Hagan, Wei Zhang, Rajita Vatapalli, Marilia Freitas Calmon, Ludmila Danilova, Claudia Nelkenbrecher, Leander Van Neste, Ingrid T.G.W. Bijsmans, Manon Van Engeland, Edward Gabrielson, Kornel E. Schuebel, Andreas Winterpacht, Stephen B. Baylin, James G. Herman and Nita Ahuja
    Clin Cancer Res June 15 2013 19 (12) 3201-3211; DOI:10.1158/1078-0432.CCR-12-3751

  • Cancer Therapy: Preclinical
    Cap-Translation Inhibitor, 4EGI-1, Restores Sensitivity to ABT-737 Apoptosis through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia
    Shaun Willimott, Daniel Beck, Matthew J. Ahearne, Victoria C. Adams and Simon D. Wagner
    Clin Cancer Res June 15 2013 19 (12) 3212-3223; DOI:10.1158/1078-0432.CCR-12-2185

  • Cancer Therapy: Preclinical
    Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade
    Qian Chu, Brent A. Orr, Samantha Semenkow, Eli E. Bar and Charles G. Eberhart
    Clin Cancer Res June 15 2013 19 (12) 3224-3233; DOI:10.1158/1078-0432.CCR-12-2119

  • Cancer Therapy: Preclinical
    Monoclonal Antibody against the Ectodomain of E-Cadherin (DECMA-1) Suppresses Breast Carcinogenesis: Involvement of the HER/PI3K/Akt/mTOR and IAP Pathways
    Sabine M. Brouxhon, Stephanos Kyrkanides, Xiaofei Teng, Veena Raja, M. Kerry O'Banion, Robert Clarke, Stephen Byers, Andrew Silberfeld, Carmen Tornos and Li Ma
    Clin Cancer Res June 15 2013 19 (12) 3234-3246; DOI:10.1158/1078-0432.CCR-12-2747

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer Outcome
    Katia Todoerti, Luca Agnelli, Sonia Fabris, Marta Lionetti, Giacomo Tuana, Laura Mosca, Luigia Lombardi, Vitina Grieco, Gabriella Bianchino, Fiorella D'Auria, Teodora Statuto, Carmela Mazzoccoli, Luciana De Luca, Maria Teresa Petrucci, Fortunato Morabito, Massimo Offidani, Francesco Di Raimondo, Antonietta Falcone, Paola Omede', Pierfrancesco Tassone, Mario Boccadoro, Antonio Palumbo, Antonino Neri and Pellegrino Musto
    Clin Cancer Res June 15 2013 19 (12) 3247-3258; DOI:10.1158/1078-0432.CCR-12-3461

  • Imaging, Diagnosis, Prognosis
    Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
    A. Ari Hakimi, Irina Ostrovnaya, Boris Reva, Nikolaus Schultz, Ying-Bei Chen, Mithat Gonen, Han Liu, Shugaku Takeda, Martin H. Voss, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Emily H. Cheng, Chris Sander, Robert J. Motzer and James J. Hsieh; for The ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators
    Clin Cancer Res June 15 2013 19 (12) 3259-3267; DOI:10.1158/1078-0432.CCR-12-3886

  • Imaging, Diagnosis, Prognosis
    EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions
    Juliana Schussel, Xian Chong Zhou, Zhe Zhang, Kavita Pattani, Francisco Bermudez, Germain Jean-Charles, Thomas McCaffrey, Tapan Padhya, Joan Phelan, Silvia Spivakovsky, Mariana Brait, Ryan Li, Helen Yoo Bowne, Judith D. Goldberg, Linda Rolnitzky, Miriam Robbins, A. Ross Kerr, David Sirois and Joseph A. Califano
    Clin Cancer Res June 15 2013 19 (12) 3268-3275; DOI:10.1158/1078-0432.CCR-12-3496

  • Imaging, Diagnosis, Prognosis
    Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
    Heidrun Gevensleben, Isaac Garcia-Murillas, Monika K. Graeser, Gaia Schiavon, Peter Osin, Marina Parton, Ian E. Smith, Alan Ashworth and Nicholas C. Turner
    Clin Cancer Res June 15 2013 19 (12) 3276-3284; DOI:10.1158/1078-0432.CCR-12-3768

  • Imaging, Diagnosis, Prognosis
    PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer
    Fiona L. Day, Robert N. Jorissen, Lara Lipton, Dmitri Mouradov, Anuratha Sakthianandeswaren, Michael Christie, Shan Li, Cary Tsui, Jeannie Tie, Jayesh Desai, Zheng-Zhou Xu, Peter Molloy, Vicki Whitehall, Barbara A. Leggett, Ian T. Jones, Stephen McLaughlin, Robyn L. Ward, Nicholas J. Hawkins, Andrew R. Ruszkiewicz, James Moore, Dana Busam, Qi Zhao, Robert L. Strausberg, Peter Gibbs and Oliver M. Sieber
    Clin Cancer Res June 15 2013 19 (12) 3285-3296; DOI:10.1158/1078-0432.CCR-12-3614

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes
    Carla Filì, Michele Malagola, Matilde Y. Follo, Carlo Finelli, Ilaria Iacobucci, Giovanni Martinelli, Federica Cattina, Cristina Clissa, Anna Candoni, Renato Fanin, Marco Gobbi, Monica Bocchia, Marzia Defina, Pierangelo Spedini, Cristina Skert, Lucia Manzoli, Lucio Cocco and Domenico Russo
    Clin Cancer Res June 15 2013 19 (12) 3297-3308; DOI:10.1158/1078-0432.CCR-12-3540

  • Cancer Therapy: Clinical
    A Review of Study Designs and Outcomes of Phase I Clinical Studies of Nanoparticle Agents Compared with Small-Molecule Anticancer Agents
    Whitney P. Caron, Katherine P. Morgan, Beth A. Zamboni and William C. Zamboni
    Clin Cancer Res June 15 2013 19 (12) 3309-3315; DOI:10.1158/1078-0432.CCR-12-3649

Predictive Biomarkers and Personalized Medicine

  • Predictive Biomarkers and Personalized Medicine
    CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
    Anne-Joy M. de Graan, Laure Elens, Jason A. Sprowl, Alex Sparreboom, Lena E. Friberg, Bronno van der Holt, Pleun J. de Raaf, Peter de Bruijn, Frederike K. Engels, Ferry A.L.M. Eskens, Erik A.C. Wiemer, Jaap Verweij, Ron H.J. Mathijssen and Ron H.N. van Schaik
    Clin Cancer Res June 15 2013 19 (12) 3316-3324; DOI:10.1158/1078-0432.CCR-12-3786

Letters to the Editor

  • Letters to the Editor
    Plasma MicroRNAs in Ovarian Cancer—Letter
    Haifeng Qiu
    Clin Cancer Res June 15 2013 19 (12) 3325-3325; DOI:10.1158/1078-0432.CCR-13-0561

  • Letters to the Editor
    Plasma MicroRNAs in Ovarian Cancer—Response
    Xin Huang and Anda M. Vlad
    Clin Cancer Res June 15 2013 19 (12) 3326-3326; DOI:10.1158/1078-0432.CCR-13-1022

Retraction

  • Retraction
    Retraction: Functional Characterization of the Bladder Cancer Marker, BLCA-4
    Clin Cancer Res June 15 2013 19 (12) 3327-3327; DOI:10.1158/1078-0432.CCR-13-1145

Back to top
PreviousNext
Clinical Cancer Research: 19 (12)
June 2013
Volume 19, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Cap-Translation Inhibitor, 4EGI-1, Restores Sensitivity to ABT-737 Apoptosis through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia
  • ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
  • microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics
  • Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade
  • PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer

Jump to

  • Highlights
  • CCR Translations
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Predictive Biomarkers and Personalized Medicine
  • Letters to the Editor
  • Retraction
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement